Using social cognitive theory to explain consumers' behavioral intentions in response to direct-to-consumer prescription drug advertising

• Published in: Research in social and administrative pharmacy 2005-06, Vol.1 (2), p.270-288
• Main Authors: Young, Henry N., Lipowski, Earlene E., Cline, Rebecca J.W.
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Advertising as Topic; Attitude to Health; Communication; Data Collection; Female; Health Behavior; Humans; Pharmaceutical Preparations; Physician-Patient Relations; Self Efficacy
• ISSN: 1551-7411; 1934-8150
• DOI: 10.1016/j.sapharm.2005.03.011

Previous research describing consumers' communication behaviors in response to direct-to-consumer advertising (DTCA) suggests a social cognitive rationale to explain DTCA-related communication behavior. Guided by social cognitive theory, the objective of this study was to explore outcome expectancy and self-efficacy beliefs as predictors of individuals' intentions to communicate with their physicians about an advertised drug. One hundred and seven female college students completed a questionnaire, read an advertisement for an oral contraceptive drug, and completed a second questionnaire. The questionnaires assessed participants' self-efficacy and outcome expectancy beliefs, intended communication behavior, and demographic information. Pearson product-moment correlation analyses showed that outcome expectancy ( r = 0.75, P < .01) and self-efficacy ( r = 0.21, P < .05) beliefs were associated positively with intentions to communicate with physicians in response to DTCA. However, ordinary least squares regression analyses revealed that only outcome expectancy beliefs predicted intended communication behavior ( B = 1.56, P < .01). Results also showed that participants had a relatively greater likelihood of requesting information about, than requesting a prescription for, the advertised drug [ t(106) = 14.75, P < .01]. The results identify cognitive factors that guide consumers' plans for interacting with physicians in response to DTCA. Health care providers can use these results to guide communication with patients regarding DTCA and meet patients' drug-related informational expectations.